[Premenstrual syndrome. New therapeutic trial: oral thiomucase].
D000284:Administration, Oral; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006026:Glycoside Hydrolases / Q000008:administration & dosage*; D006801:Humans; D008599:Menstruation Disturbances / Q000188:drug therapy*; D011293:Premenstrual Syndrome / Q000188:drug therapy
D006026:Glycoside Hydrolases
Le syndrome prémenstruel. Nouvel essai thérapeutique: la Thiomucase orale.